Stock price when the opinion was issued
EMR has a total return of 33% over the last year and forward price-to-earnings ratio is decent, however not low at 20.8x. EMR also pays a small yield of 1.84%. Revenue growth has been modest over the last few years, however, margins have expanded nicely and most recent earnings were very strong. The balance sheet also looks OK with plenty of cash despite highly leveraged. We think EMR is a good name and forecasts predict a strong 2024. It appears to be quite a stable business, generating high cash flows and returns capital to shareholders well through the dividend and buybacks.
Unlock Premium - Try 5i Free
Well-run. Maybe buy it during this pullback and she is certainly watching it. The U.S. has picked up oil demand, so Emerson's orders have grown.